Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. Sino Biopharmaceutical Limited
  6. News
  7. Summary
    1177   KYG8167W1380

SINO BIOPHARMACEUTICAL LIMITED

(1177)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Sino Biopharmaceutical : Gets Registration Approval for Hepatitis Treatment in China

09/02/2021 | 05:36am EDT


ę MT Newswires 2021
All news about SINO BIOPHARMACEUTICAL LIMITED
10/08SINO BIOPHARMACEUTICAL : Anti-Tumor Drug Registration Accepted in China
MT
10/08SINO BIOPHARMACEUTICAL : Gets US FDA Nod for Clinical Trial of Cough, Pain Treatment
MT
10/08Sino Biopharmaceutical Limited Announces IND Application of Innovative Medicine "Tcr167..
CI
09/13SINO BIOPHARMACEUTICAL LIMITED : Ex-dividend day for quarterly dividend
FA
09/02SINO BIOPHARMACEUTICAL : Receives Registration Approval for Cancer Treatment in China
MT
09/02SINO BIOPHARMACEUTICAL : Gets Registration Approval for Hepatitis Treatment in China
MT
09/01Hong Kong Hang Seng Rises 0.6%, Led by Tech Sector
MT
09/01Sino Biopharmaceutical Limited Announces Sofosbuvir Tablets Obtains Drug Registration C..
CI
09/01Sino Biopharmaceutical Limited's Lenvatinib Mesilate Capsule Obtains Drug Registration ..
CI
08/31Sino Biopharmaceutical Limited Announces Second Ordinary Interim Dividend for the Finan..
CI
More news
Analyst Recommendations on SINO BIOPHARMACEUTICAL LIMITED
More recommendations
Financials
Sales 2021 34 122 M 4 388 M 4 388 M
Net income 2021 10 394 M 1 337 M 1 337 M
Net cash 2021 10 637 M 1 368 M 1 368 M
P/E ratio 2021 11,9x
Yield 2021 2,16%
Capitalization 113 B 14 497 M 14 500 M
EV / Sales 2021 2,99x
EV / Sales 2022 2,40x
Nbr of Employees 24 443
Free-Float 52,2%
Chart SINO BIOPHARMACEUTICAL LIMITED
Duration : Period :
Sino Biopharmaceutical Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SINO BIOPHARMACEUTICAL LIMITED
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 26
Last Close Price 6,01 HKD
Average target price 10,59 HKD
Spread / Average Target 76,2%
EPS Revisions
Managers and Directors
Yi Li Chief Executive Officer & Executive Director
Theresa Tse Chairman
Hsuan Tse General Manager-Information Management
Wei Nong Ye General Manager-Research & Development
Mao Li Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
SINO BIOPHARMACEUTICAL LIMITED-19.87%14 497
JOHNSON & JOHNSON2.49%424 619
ROCHE HOLDING AG16.59%339 442
NOVO NORDISK A/S54.22%234 792
PFIZER, INC.13.20%232 621
ELI LILLY AND COMPANY40.89%215 657